Your browser doesn't support javascript.
loading
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
Thurmaier, Johannes; Heinemann, Volker; Engel, Jutta; Schubert-Fritschle, Gabriele; Wiedemann, Max; Nüssler, Natascha C; Ruppert, Reinhard; Kleeff, Jörg; Schepp, Wolfgang; Löhe, Florian; Karthaus, Meinolf; Neumann, Jens; Kumbrink, Jörg; Taverna, Francesco; Stahler, Arndt; Heinrich, Kathrin; Westphalen, Christoph Benedikt; Holch, Julian W; Kirchner, Thomas; Michl, Marlies.
Afiliação
  • Thurmaier J; Department of General Pediatrics, Ostschweizer Kinderspital, St. Gallen, Switzerland.
  • Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Engel J; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
  • Schubert-Fritschle G; German Cancer Consortium (DKTK); German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Wiedemann M; Munich Cancer Registry (MCR), Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Nüssler NC; Institute of Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University of Munich, Germany.
  • Ruppert R; Munich Cancer Registry (MCR), Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Kleeff J; Institute of Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University of Munich, Germany.
  • Schepp W; Munich Cancer Registry (MCR), Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Löhe F; Institute of Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University of Munich, Germany.
  • Karthaus M; Department of Surgery, München Klinik Neuperlach, Munich, Germany.
  • Neumann J; Department of Surgery, München Klinik Neuperlach, Munich, Germany.
  • Kumbrink J; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Germany.
  • Taverna F; Department of Gastroenterology, Hepatology and Gastrointestinal Oncology, München Klinik Bogenhausen, Munich, Germany.
  • Stahler A; Department of Surgery, Klinikum Landshut, Landshut, Germany.
  • Heinrich K; Department of Hematology, Oncology and Palliative Care, München Klinik Harlaching and Neuperlach, Munich, Germany.
  • Westphalen CB; German Cancer Consortium (DKTK); German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Holch JW; Institute of Pathology, Ludwig-Maximilians-University of Munich, Germany.
  • Kirchner T; German Cancer Consortium (DKTK); German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Michl M; Institute of Pathology, Ludwig-Maximilians-University of Munich, Germany.
Int J Cancer ; 148(8): 1919-1927, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33113215
The aim of the study was to investigate the predictive impact of extracranial metastatic patterns on course of disease and survival in patients with colorectal cancer (CRC) and brain metastasis (BM). A total of 228 patients (134 male [59%], 94 female [41%]) with histologically proven CRC and BM were classified into different groups according to extracranial metastatic patterns. Time intervals to metastatic events and survival times from initial CRC diagnosis, extracranial and intracranial metastasis were analyzed. Extracranial organs mostly affected were liver (102 of 228 [44.7%]) and lung (96 of 228 [42.1%]). Liver and lung metastases were detected in 31 patients (13.6%). Calculated over the entire course of disease, patients with lung metastasis showed longer overall survival (OS) than patients with liver metastasis or patients without lung metastasis (43.9 vs 34.6 [P = .002] vs 35.0 months [P = .002]). From the date of initial CRC diagnosis, lung metastasis occurred later in CRC history than liver metastasis (24.3 vs 7.5 months). Once lung metastasis was diagnosed, BM occurred faster than in patients with liver metastasis (15.8 vs 26.0 months; Δ 10.2 months). Accordingly, OS from the diagnosis of liver metastasis was longer than from lung metastasis (27.1 vs 19.6 months [P = .08]). Once BM was present, patients with lung metastasis lived longer than patients with liver metastasis (3.8 vs 1.1 months [P = .028]). Shortest survival times in all survival categories analyzed revealed patients with concurrent liver and lung metastasis. Patients with CRC and BM form a heterogeneous cohort where extracranial metastasis to liver or lungs predicts survival.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Colorretais / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Colorretais / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça